Evidence map›Paper›PMID 34367449›Full record

ArticleThe Pan African medical journal2021

Orofacial lesions associated with long-term highly active antiretroviral therapy among HIV-seropositive adults in Ibadan, Nigeria.

Oluwatoyin Elizabeth Abe, Omotayo Francis Fagbule, Oluwatobi Olubusi Olaniyi, Akinyele Olumuyiwa Adisa, Olalere Omoyosola Gbolahan

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Oluwatoyin Elizabeth AbeDepartment of Oral Pathology and Oral Medicine, University College Hospital, Ibadan, Nigeria.
Omotayo Francis FagbuleDepartment of Periodontology and Community Dentistry, University College Hospital, Ibadan, Nigeria.
Oluwatobi Olubusi OlaniyiInfectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Akinyele Olumuyiwa AdisaDepartment of Oral Pathology and Oral Medicine, University College Hospital, Ibadan, Nigeria.
Olalere Omoyosola GbolahanDepartment of Oral and Maxillofacial Surgery, College of Medicine, University of Ibadan/ University College Hospital, Ibadan, Nigeria.
University College Hospital, Ibadan · NGUniversity of Ibadan · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionhighly active antiretroviral therapy (HAART) has contributed to a reduction in HIV- related oral lesions and improved quality of life among HIV seropositive patients. However, the therapy is not without its side effects. This study was aimed at assessing the self- reported orofacial manifestations due to long term use of HAART, as well as the pattern of oral lesions on examination.

methodsthis was a cross-sectional study conducted among HIV seropositive adult patients in Ibadan, who had been on HAART for at least two years. Data were collected using an interviewer-administered questionnaire. Clinical diagnosis of HIV-related oral lesions was made according to the EC-Clearinghouse criteria. Data analysis was done using SPSS version 25.

resultsthe study participants comprised of 227 HIV seropositive patients who were HAART experienced, with 54 (24%) males and 173 (76%) females. Their mean age (±SD) was 44.7 (±9.4) years. The participants CD4 count ranged from 13-1338cells/mm

conclusionmelanotic hyperpigmentation was the most common oral lesion found and burning mouth syndrome was the most commonly reported complain among HIV-seropositive adults who are on long-term HAART.

Indexed as

AdolescentAdultAgedAged, 80 and overAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountCross-Sectional StudiesFemaleHIV InfectionsHumansMaleMiddle AgedMouth DiseasesNigeriaQuality of LifeSurveys and QuestionnairesCD4 countHighly active antiretroviral therapyHIV/AIDSHIV-seropositivityNigeriaoral candidiasisoral ulcersorofacial lesions

Identifiers

PMID34367449
PMCPMC8308855
OpenAlexW3154033150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.